Dallas Fort Worth Injury Lawyer Blog

September 13, 2013

Warning Alert J&J Red Cap Tylenol Liver Failure

As a Texas medical doctor and Dangerous Drugs attorney, I have been warning about the serious and potentially deadly side effects of this commonly used medication. I have had personal experience of the liver damage that this drug can inflict on the young, elderly and sick patients, during my years as working as an ER physician.

Many a night we struggled to save the lives of young kids who would take Tylenol overdoses as a means of committing suicide. In some instances, the children died, some we managed to save with aggressive medical treatments.

According to experts, almost a quarter of patients take more than the recommended dose, which could result in accidental Tylenol overdoses, increasing the risk of liver failure or death.

September 2, 2013

DePuy ASR Hip Failure Lawsuits Heading to Settlement?

by Dr. Shezad Malik

According to sources, Johnson & Johnson (J&J) and its subsidiary DePuy, are in active discussions to attempt a global settlement of their defective ASR metal on metal artificial hips.

J&J Potential Settlement North of $3 Billion

Apparently J&J has discussed paying more than $3 billion to settle lawsuits over its recalled hip implants. J&J is exposed to over 11,500 product liability lawsuits in the U.S. and is considering paying more than $300,000 per case. According to experts, such a global settlement would surpass $3 billion if most plaintiffs accept the proposed terms, this valuation is 50% larger than previously proposed.

September 2, 2013

Biomet M2A Metallosis Hip Failure Cases Update

by Dr. Shezad Malik

The federal judge overseeing the Biomet M2A Magnum hip failure lawsuits has denied a motion to dismiss the lawsuits based on federal preemption. Many plaintiffs have filed product liability lawsuits over early hip failure and metallosis involving the Biomet metal hip replacement device.

Plaintiff Biomet Injuries

The plaintiff, Leslie Caccia, had to undergo multiple revision surgeries after his Biomet ReCap Femoral Resurfacing System and M2A-Magnum metal-on-metal hip replacement system prematurely failed.

September 2, 2013

Bard Settles 2nd Avaulta Transvaginal Mesh Lawsuit

by Dr. Shezad Malik

Recently, Bard settled the second federal Avaulta bellwether trial over its alleged defective transvaginal mesh devices. The settlement was announced by U.S. District Judge Goodwin, who is supervising the transvaginal mesh product liability lawsuits in Charleston, W.Va.

As previously noted, in the first Bard Avaulta bellwether trial, the jury awarded $2 million to a woman who claimed that Bard failed to warn of defects in its product that caused her mesh side effects. The settlement ended the second trial, brought by a North Carolina woman, Wanda Queen. A third bellwether case goes to trial on October 8 and a fourth on November 4.

Over 20,000 Trans Vaginal Mesh Lawsuits Pending

September 2, 2013

Byetta, Januvia Pancreatic Cancer Lawsuits

by Dr. Shezad Malik

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has agreed to consolidate all Byetta, Januvia, Janumet and Victoza cancer lawsuits, centralizing the litigation as part of an MDL, or Multidistrict Litigation. The JPML issued a Transfer Order on August 26, and these product liability cases involve pancreatic cancer after the use of Byetta, Januvia, Janumet or Victoza as part of the “Incretin Mimetics Product Liability Litigation.”

The product liability cases will be centralized before U.S. District Judge Battaglia in the Southern District of California for coordinated handling during pretrial proceedings. The consolidation is beneficial for all parties in complex pharmaceutical litigation, to reduce repetative discovery and to prevent conflicting rulings from different federal judges.

What are Incretin Mimetics?

September 1, 2013

Stryker Oasys Occipito-Cervico-Thoracic System Recalled

by Dr. Shezad Malik

Stryker, a well known artificial hip and medical device manufacturer, is recalling devices used in spinal surgeries. The FDA has assigned its most serious warning label to the problem, indicating that using the device could result in serious injury or death. Stryker is already under fire over lawsuits involving its Stryker Rejuvenate and ABG II artificial hips, amid allegations of early failure of the devices and the risk of metallosis. Metallosis occurs when the component parts grind against each other releasing metal ions into the bloodstream and hip joint, leading to loosening of the hip device, bone destruction, pain and swelling.

The device is the Oasys Occipito-Cervico-Thoracic System, which is designed to stabilize the junction between the occipital bone and vertebrae in the cervical spine.

Stryker has received reports that a pin that connects the tulip head to the plate body can fracture, possibly causing blood loss, nerve injury and the need for revision surgery. The FDA put its Class I designation on the recall, a notification for potentially deadly malfunctions.

August 30, 2013

Tylenol Liver Failure and Red Cap Warnings

by Dr. Shezad Malik

As a Texas medical doctor and Dangerous Drugs attorney, I have been warning about the serious and potentially deadly side effects of this commonly used medication. I have had personal experience of the liver damage that this drug can inflict on the young, elderly and sick patients, during my years as working as an ER physician.

Many a night we struggled to save the lives of young kids who would take Tylenol overdoses as a means of committing suicide. In some instances, the children died, some we managed to save with aggressive medical treatments.

According to experts, almost a quarter of patients take more than the recommended dose, which could result in accidental Tylenol overdoses, increasing the risk of liver failure or death.

August 21, 2013

NuvaRing DVT and Pulmonary Embolism Settlement?

by Dr. Shezad Malik

According to Merck company filings, there are now about 1,500 filed product liability lawsuits involving injuries from NuvaRing blood clots. These women claim that the contraceptive ring increased the risk of blood clots, other serious and potentially deadly side effects.

What is Nuvaring?

NuvaRing is a vaginal contraceptive ring, made by Merck’s Organon subsidiary, which is placed in the vagina. The ring releases a combination of estrogen, ethinyl estradiol and the “third generation” progestin, etonogestrel. The ring is replaced every month.

August 20, 2013

Bard Avaulta Vaginal Mesh Trial $2M Plaintiff’s Verdict

by Dr. Shezad Malik

Last week, a federal jury in West Virginia awarded $2 million in damages in a Bard Avaulta vaginal mesh defective product liability claim. The verdict included punitive damages to punish CR Bard Inc., the manufacturer for selling a defective product that has been linked to severe internal injuries.

This is the first federal Vaginal Mesh verdict, in more than 25,000 vaginal mesh lawsuits pending in the federal court system.

Plaintiff Suffered Serious Injuries

August 19, 2013

Medtronic Infuse Injury Lawsuits Update

by Dr. Shezad Malik

Medtronic Infuse product liability lawsuits involving Medtronic Infuse bone graft surgery, have hit a federal preemption roadblock. Federal preemption law, for medical devices, is based on a 2008 Supreme Court ruling that has been used as an impregnable defense wall by medical device manufacturers.

Medtronic has argued that they can not be held liable for injuries, since the device was approved by the FDA. The medical device maker’s argument was upheld in the Supreme Court decision of Riegel v. Medtronic, involving allegedly defective pacemaker leads and injuries.

What is Medtronic Infuse?